The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.
The Effect of Chlorpromazine (Largactil®), a Dopamine Receptor Antagonist, on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Double-blind, Placebo-controlled Study.
Sponsor: Universitaire Ziekenhuizen KU Leuven
A NA clinical study on Esophageal Reflux, this trial is ongoing. The trial is conducted by Universitaire Ziekenhuizen KU Leuven and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status NA
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Jul 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .